Calidi Biotherapeutics, Inc. has filed 390 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-16 | Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement |
| 3 | 2026-06-29 | Initial Statement of Beneficial Ownership |
| 8-K | 2026-06-23 | Departure/Appointment of Directors or Officers; Regulation FD Disclosure |
| 8-K | 2026-06-18 | Submission of Matters to a Vote of Security Holders |
| DEFA14A | 2026-06-05 | Additional Proxy Soliciting Materials |
| 8-K | 2026-05-29 | Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| SC 13G | 2026-05-15 | Beneficial Ownership Report (Passive) |
| 10-Q | 2026-05-14 | Quarterly Report |
| 8-K | 2026-05-14 | Results of Operations and Financial Condition; Regulation FD Disclosure |
| 8-K | 2026-05-08 | Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |